Magnus E M
Krohgstoetten Department, Oslo University Hospital, Norway.
Eur J Haematol. 1987 Jul;39(1):39-43. doi: 10.1111/j.1600-0609.1987.tb00161.x.
27 patients with pernicious anaemia, followed for a long period, were consecutively treated with three different vitamin B12 preparations, while during intervening period no therapy was given until signs of B12 deficiency developed. After vitamin B12 treatment, a peak whole blood folate value some 70% higher than the starting value was noted after about 75 d in patients treated with B12 injections and after about 165 d in perorally treated patients. During the same time significantly increased whole blood folate/plasma folate ratio was noted. In most of the patients, whole blood folate declined from peak to plateau level in about 150 d and thereafter remained almost unchanged until signs of cobalamin deficiency developed. The mean time from peak to plateau values was significantly longer in "long-reactors" than in "short-reactors". Higher peak and plateau values were noted in patients with neuropathy and mucosal symptoms, as compared to patients with hypersegmentation.
27例长期随访的恶性贫血患者连续接受三种不同的维生素B12制剂治疗,在干预期间,直至出现维生素B12缺乏迹象之前不给予任何治疗。维生素B12治疗后,接受B12注射治疗的患者在约75天后全血叶酸峰值比起始值高约70%,口服治疗的患者在约165天后出现此情况。同时,全血叶酸/血浆叶酸比值显著升高。在大多数患者中,全血叶酸在约150天内从峰值降至平台期水平,此后几乎保持不变,直至出现钴胺素缺乏迹象。“长反应者”从峰值到平台期值的平均时间明显长于“短反应者”。与有核分叶过多的患者相比,有神经病变和黏膜症状的患者峰值和平台期值更高。